Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered ...

In one, colchicine proved to be no better than placebo for pain relief or patient-reported functional improvement in OA of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

Acetaminophen use, which was allowed as needed, was not taken less often by patients assigned to colchicine. (HealthDay News) — Colchicine fails to improve knee pain, function, or size of ...

Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be investigated as a potential therapy for COVID-19 in the UK’s ground-breaking ...

WASHINGTON, DC—The short-term use of colchicine at the time of TAVI for severe aortic stenosis may curb the risk of new-onset atrial fibrillation (AF) and the need for a new permanent pacemaker, the ...

Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 ...

The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial ...

In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine did not reduce ...